Authors: Gaci, Z Bouin-Pineau, MH Gaci, M Daban, A Ingrand, P Metaye, T

Citation: Z. Gaci et al., Prognostic impact of cathepsin D and c-erbB-2 oncoprotein in a subgroup ofnode-negative breast cancer patients with low histological grade tumors, INT J ONCOL, 18(4), 2001, pp. 793-800

Authors: Metaye, T Desmarquet, M Rosenberg, T Guilhot, J Bouin-Pineau, MH

Citation: T. Metaye et al., Rapid quality control for testing the radiochemical purity of Tc-99(m)-tetrofosmin, NUCL MED C, 22(10), 2001, pp. 1139-1144

Authors: Dormer, RL Derand, R McNeilly, CM Mettey, Y Bulteau-Pignoux, L Metaye, T Vierfond, JM Gray, MA Galietta, LJV Morris, MR Pereira, MMC Doull, IJM Becq, F McPherson, MA

Citation: Rl. Dormer et al., Correction of delF508-CFTR activity with benzo(c)quinolizinium compounds through facilitation of its processing in cystic fibrosis airway cells, J CELL SCI, 114(22), 2001, pp. 4073-4081

Authors: Bulteau, L Derand, R Mettey, Y Metaye, T Morris, MR McNeilly, CM Folli, C Galietta, LJV Zegarra-Moran, O Pereira, MMC Jougla, C Dormer, RL Vierfond, JM Joffre, M Becq, F

Citation: L. Bulteau et al., Properties of CFTR activated by the xanthine derivative X-33 in human airway Calu-3 cells, AM J P-CELL, 279(6), 2000, pp. C1925-C1937

Authors: Becq, F Mettey, Y Gray, MA Galietta, LJV Dormer, RL Merten, M Metaye, T Chappe, V Marvingt-Mounir, C Zegarra-Moran, O Tarran, R Bulteau, L Derand, R Pereira, MMC McPherson, MK Rogier, C Joffre, M Argent, BE Sarrouilhe, D Kammouni, W Figarella, C Verrier, B Gola, M Vierfond, JM

Citation: F. Becq et al., Development of substituted benzo[c]quinolizinium compounds as novel activators of the cystic fibrosis chloride channel, J BIOL CHEM, 274(39), 1999, pp. 27415-27425